跳至主要内容
临床试验/NCT02300181
NCT02300181已完成不适用

A Randomized, Double-blind, Placebo Controlled, Crossover Study to Determine the Effect of the Flour Fermentation Products by Bacillus Subtilis Var Natto DC-15 on Postprandial Glucose Profile in Prediabetic Subjects.

Hiroshima University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Difference in plasma glucose profile including AUC and Cmax after taking 50 g carbohidrate.

研究概览

简要总结

The purpose of the present study is to evaluate the effect of the extract of the flour fermented with Bacillus subtilis var natto DC-15 on postprandial glucose level in subjects with prediabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Fasting plasma glucose 110-125 mg/dL

排除标准

  • •Taking anti-diabetic drugs
  • •Taking drugs or functional food that may affect blood glucose level
  • •Pregnant or nursing a child
  • •Participation in any clinical trial within 90 days of the commencement of the trial
  • •Renal or hepatic dysfunction
  • •Heart disease
  • •History of severe disease and/or major surgery

研究组 & 干预措施

Placebo (flour)

Placebo Comparator

5 placebo capsules for each test (4.88 kcal/5 cap)

干预措施: Placebo (Dietary Supplement)

Bacillus subtilis var natto DC-15

Experimental

5 experimental capsules for each test (4.96 kcal/5 cap) Extract powder of the flour fermented with Bacillus subtilis var natto DC-15

干预措施: Bacillus subtilis var natto DC-15 (Dietary Supplement)

结局指标

主要结局

Difference in plasma glucose profile including AUC and Cmax after taking 50 g carbohidrate.

时间窗: Overall 3 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fumiko Higashikawa

Associate Professor

Hiroshima University

研究点 (1)

Loading locations...

相似试验

Effect of the Extract of the Flour Fermented With... | 临床试验